-
Study aim
-
To investigate the effect of consuming four plant extracts on kidney stone excretion following extracorporeal lithotripsy
-
Design
-
A concealed, randomized, blinded, sham controlled clinical trial, phase 3 design of 62 patients
-
Settings and conduct
-
We select 62 patients referred to the lithotripsy department of Imam Jafar Sadeq Hospital in Meybod with the aforementioned conditions whom undergo an abdominopelvic CT scan without contrast before lithotripsy. Then, the patient undergo lithotripsy, and randomized into two groups by concealed envelope. One group is given antibiotics and analgesics and syrup of four herbal extracts, the other receive placebo for 40 days (10 cc, three times a day). Then, a kidney ultrasound has been done. At the end of the study, the presence or absence of stones and the size of the stone remnants are checked and compared between two groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: 1. The stone size is between 1-2 cm. 2. The stone's Hounsfield number is below 1000. 3. The age is over 18 years. 4. The distance between the stone and the skin surface is less than 10 cm.
Exclusion criteria: 1. Urinary tract infection symptoms 2. History of DJ insertion; 3. Does not consent to participate in the study 4. Developing post-ESWL complications 5. Does not complete post-lithotomy follow-up. 6. Any anatomical abnormalities in the kidney undergoing lithotripsy. 8. Pregnant women and children. 9. Allergy to any of the ingredients of the prescribed drug
-
Intervention groups
-
The intervention group (31 eligible patients) is given antibiotics, painkillers, and extracts of four herbs for 40 days (three times a day, 10 cc each time). The control group (31 eligible patients) is given antibiotics, painkillers, and a placebo for 40 days (three times a day, 10 cc each time).
-
Main outcome variables
-
Stone passage rate after extracorporeal lithotripsy following drug use